Background: This study reports our experience in the nonsurgical closure of
perimembranous ventricular septal defects in children and adolescents with the Amplatzer …

Objective: To close perimembranous ventricular septal defects (PMVSDs) in children with
the new Amplatzer asymmetric ventricular septal defect occluder (AAVSDO). Patients and …

There are very few published reports of the transcatheter closure of perimembranous
ventricular septal defects (PMVSDs) using the Amplatzer PMVSD occluder with encouraging …

ObjectiveThe objective of this study was to explore the clinical effect of the transcatheter
closure of congenital perimembranous ventricular septal defect using the Amplatzer duct …

Percutaneous closure of perimembranous ventricular septal defects (VSDs) has been
feasible, safe, and effective with the new Amplatzer membranous septal occluder. We report …

Background: Transcatheter closure of perimembranous ventricular septal defect with the use
of an Amplatzer occluder was introduced in 1999, however, clinical experience with this …

Using an Amplatzer membranous eccentric occluder, 186 patients with an average weight of
43.5 kg (range 12.5–77) underwent attempted catheter closure of a perimembranous …

Objective Percutaneous closure of perimembranous ventricular septal defect is one of the
greatest challenges in interventional cardiology. The long‐term follow‐up data are still …

The isolated perimembranous ventricular septal defect is one of the most common
congenital cardiac malformations. Although surgery has been performed and has a low …

Objectives: This phase I study attempted to report the initial safety and efficacy results of
transcatheter closure of perimembranous ventricular septal defects (PmVSDs) using the new …